Skip to content
Catalyst

PapersPMID:37468886

Comparison of the effect of vaginal misoprostol and evening primrose oil capsule with misoprostol alone on the consequences of abortion in women with intrauterine fetal death: a randomized clinical trial.

BMC complementary medicine and therapies2023The record ↗

  1. Finding, moderate evidencelowersVisual analogue scale pain intensity

What moved

1 findingHow to read these marks →
  • “Table  1 shows that the mean pain intensity in the induction-to-fetal expulsion interval in the experimental group was significantly lower than in the control group.”
    Study
    RCT
    Dose studied
    1000 mg EPO capsule intravaginal every 4 h, up to five doses, with each misoprostol dose
    Population
    women at 12-20 weeks of pregnancy with intrauterine fetal death undergoing induced abortion, all receiving 200 mcg vaginal misoprostol every 4 h (up to five doses) in both arms; highest pain intensity during the induction-to-fetal expulsion interval on a 10-cm VAS

Study record

Design
randomised controlled trial
Species
human
Population
Iranian pregnant women at 12-20 weeks with intrauterine fetal death undergoing induced abortion; evening primrose oil given intravaginally (1000 mg capsule) with vaginal misoprostol, versus placebo capsule with misoprostol
Participants
82
Comparator
placebo
Duration
not reported
Endpoints measured
30